Edit |   |
---|---|
Antigenic Specificity | RET |
Clone | polyclonal |
Host Species | Goat |
Reactive Species | human. expected from sequence similarity: human |
Isotype | n/a |
Format | antigen affinity purified |
Size | 0.1 mg |
Concentration | n/a |
Applications | Peptide ELISA (EIA), Immunofluorescence (IF), Flow Cytometry (FC/FACS) |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | n/a |
Immunogen | Immunogen: Peptide with sequence NDTKALRRPKCAELH, from the internal region of the protein sequence according to NP_066124.1; NP_065681.1; NP_001342145.1. Peptide Sequence: NDTKALRRPKCAELH. Epitope: Internal region |
Other Names | [RET; ret proto-oncogene (multiple endocrine neoplasia and medullary thyroid carcinoma 1, Hirschsprung disease); HGNC:9967; CDHF12; HSCR1; MEN2A; MEN2B; MTC1; PTC; RET-ELE1; RET51; RET transforming sequence; cadherin family member 12; fusion gene; hydroxyaryl-protein kinase; oncogene RET; proto-oncogene; receptor tyrosine kinase; ret proto-oncogene], [RET; RET; PTC; MTC1; HSCR1; MEN2A; MEN2B; CDHF12; CDHR16; RET-ELE1; CDHF12; CDHR16; PTC; RET51] |
Gene, Accession # | [RET], Gene ID: 5979, NCBI: NP_066124.1, UniProt: P07949 |
Catalog # | MBS423839 |
Price | $305 |
Order / More Info | RET Antibody from MYBIOSOURCE INC. |
Product Specific References | Gartner W, Mineva I, Daneva T, Baumgartner-Parzer S, Niederle B, Vierhapper H, Weissel M, Wagner L.: A newly identified RET proto-oncogene polymorphism is found in a high number of endocrine tumor patients. Hum Genet. 2005 Apr 20. PMID: 15841388 |